Zelos Therapeutics Appoints Alan S. Roemer as Chief Financial Officer

WEST CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Zelos Therapeutics, Inc. announces the appointment of Alan S. Roemer as Chief Financial Officer. Prior to joining Zelos Therapeutics, Mr. Roemer worked at Pharmasset, Inc. (Nasdaq: VRUS) from 1999 through 2008.

MORE ON THIS TOPIC